title: Color discrimination deficits in Parkinson's disease are related to cognitive impairment and white-matter alterations.
abstract: Color discrimination deficit is a common nonmotor manifestation of Parkinson's disease (PD). However, the pathophysiology of this dysfunction remains poorly understood. Although retinal structure changes found in PD have been suggested to cause color discrimination deficits, the impact of cognitive impairment and cortical alterations remains to be determined. We investigated the contribution of cognitive impairment to color discrimination deficits in PD and correlated them with cortical anomalies. Sixty-six PD patients without dementia and 20 healthy controls performed the Farnsworth-Munsell 100 hue test and underwent a comprehensive neuropsychological assessment for mild cognitive impairment diagnosis. In a subgroup of 26 PD patients, we also used high-definition neuroanatomical magnetic resonance imaging for cortical thickness and diffusion tensor analysis. PD patients with mild cognitive impairment performed poorly on the Farnsworth-Munsell 100 hue test compared with PD patients without mild cognitive impairment and controls. In PD patients, performance on the Farnsworth-Munsell 100 hue test was correlated with measures of visuospatial abilities and executive functions. Neuroimaging analysis revealed higher mean and radial diffusivity values in right posterior white-matter structures that correlated with poor performance on the Farnsworth-Munsell 100 hue test. No cortical thickness correlation reached significance. This study showed that cognitive impairment makes a major contribution to the color discrimination deficits reported in PD. Thus, performance on the Farnsworth-Munsell 100 hue test may reflect cognitive impairment more than color discrimination deficits in PD. Poor performance on the Farnsworth-Munsell 100 hue test was also associated with white-matter alterations in right posterior brain regions.
authors.affiliation: Center for Advanced Research in Sleep Medicine, Sacré-Coeur Hospital, Montreal, Québec, Canada.
authors.forename: Josie-Anne
authors.initials: JA
authors.lastname: Bertrand
authors.forename: Christophe
authors.initials: C
authors.lastname: Bedetti
authors.forename: Ronald B
authors.initials: RB
authors.lastname: Postuma
authors.forename: Oury
authors.initials: O
authors.lastname: Monchi
authors.forename: Daphné
authors.initials: D
authors.lastname: Génier Marchand
authors.forename: Thomas
authors.initials: T
authors.lastname: Jubault
authors.forename: Jean-François
authors.initials: JF
authors.lastname: Gagnon
mesh_terms: D000368:Aged; D003118:Color Perception / Q000502:physiology*; D003117:Color Vision Defects / Q000209:etiology / Q000503:physiopathology*; D005260:Female; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000379:methods; D008297:Male; D008875:Middle Aged; D010300:Parkinson Disease / Q000150:complications* / Q000473:pathology / Q000503:physiopathology